COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 1830: Articles 18291-18300  | Next

Extensive recombination-driven coronavirus diversification expands the pool of potential pandemic pathogens
Goldstein, S. A., Brown, J., Pedersen, B. S., Quinlan, A. R., Elde, N. C.
10.1101/2021.02.03.429646 — Posted: 2021-02-04
Site-specific O-glycosylation analysis of SARS-CoV-2 spike protein produced in insect and human cells
Bagdonaite, I., Thompson, A. J., Wang, X., Soegaard, M., Fougeroux, C., Frank, M., Diedrich, J. K., Yates, J. R., Salanti, A., Vakhrushev, S. Y., Paulson, J. C., Wandall, H. H.
10.1101/2021.02.03.429627 — Posted: 2021-02-04
Large-scale analysis of SARS-CoV-2 spike-glycoprotein mutants demonstrates the need for continuous screening of virus isolates
Schroers, B., Gudimella, R., Bukur, T., Roesler, T., Loewer, M., Sahin, U.
10.1101/2021.02.04.429765 — Posted: 2021-02-04
Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
Chen, X., Saccon, E., Appelberg, K. S., Mikaeloff, F., Rodriguez, J. E., Vinhas, B. S., Frisan, T., Vegvari, A., Mirazimi, A., Neogi, U., Gupta, S.
10.1101/2021.02.04.429738 — Posted: 2021-02-04
Bronchoalveolar lavage affects thorax computed tomography of healthy and SARS-CoV-2 infected rhesus macaques (Macaca mulatta)
Maaskant, A., Meijer, L., Bakker, J., van Geest, L., Zijlmans, D. G. M., Langermans, J. A. M., Verschoor, E. J., Stammes, M. A.
10.1101/2021.02.04.429761 — Posted: 2021-02-04
Targeted in situ cross-linking mass spectrometry and integrative modeling reveal the architectures of Nsp1, Nsp2, and Nucleocapsid proteins from SARS-CoV-2
Slavin, M., Zamel, J., Zohar, K., Eliyahu, S., Braitbard, M., Brielle, E., Baraz, L., Stolovich-Rain, M., Friedman, A., Wolf, D. G., Rouvinski, A., Linial, M., Schneidman-Duhovny, D., Kalisman, N.
10.1101/2021.02.04.429751 — Posted: 2021-02-04
Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH
Rensen, E. I., Pietropaoli, S., Weber, C., Souquere, S., Isnard, P., Rabant, M., Gibier, J.-B., Simon-Loriere, E., Rameix-Welti, M.-A., Pierron, G., Mueller, F., Barba-Spaeth, G., Zimmer, C.
10.1101/2021.02.04.429604 — Posted: 2021-02-04
The SARS-CoV-2 transcriptome and the dynamics of the S gene furin cleavage site in primary human airway epithelia
Zou, W., Xiong, M., Hao, S., Zhang-Chen, E. Y., Baumlin, N., Kim, M. D., Salathe, M., Yan, Z., Qiu, J.
10.1101/2021.02.03.429670 — Posted: 2021-02-04
The mutation profile of SARS-CoV-2 is primarily shaped by the host antiviral defense
Azgari, C., Kilinc, Z., Turhan, B., Circi, D., Adebali, O.
10.1101/2021.02.02.429486 — Posted: 2021-02-04 Discussion: Onsite
Estimation of infection rate and the population size potentially exposed to SARS-CoV-2 in Japan during 2020
Naito, M.
10.1101/2021.02.01.21250971 — Posted: 2021-02-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).